John A. Liu Yin

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

Alan K. Burnett, Robert K. Hills, Donald Milligan et al. · Journal of Clinical Oncology · 2010 · 652 citations · Full text

Medicine, Oncology, Pharmacology +17

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

John A. Liu Yin, Michelle A. O'Brien, Robert K. Hills et al. · Blood · 2012 · 419 citations

Medicine, Molecular Medicine, Oncology +15

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Gerhard Heil, Dieter Hoelzer, Miguel Á. Sanz et al. · Blood · 1997 · 332 citations · Full text

Medicine, Hematology, Pharmacotherapy +9

The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses <i>PCM1</i> to <i>JAK2</i>

Andreas Reiter, Christoph Walz, A. E. Watmore et al. · Cancer Research · 2005 · 262 citations

Medicine, Hematology, Oncology +14

Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy

Carolyn Owen, Cynthia L. Toze, Anna Koochin et al. · Blood · 2008 · 240 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16